Der Nuklearmediziner 2004; 27(3): 147-154
DOI: 10.1055/s-2004-822717
Kardiologie aktuell

© Georg Thieme Verlag Stuttgart · New York

Schwächungskorrektur bei der Myokardszintigraphie: Aktueller Stand

Attenuation Correction for Myocardial Scintigraphy: State-of-the-ArtO. Lindner1 , A. Kammeier1 , E. Fricke1
  • 1Institut für molekulare Biophysik, Radiopharmazie und Nuklearmedizin, Herz- und Diabeteszentrum NRW, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen
Further Information

Publication History

Publication Date:
16 September 2004 (online)

Zusammenfassung

Die Myokardperfusionsszintigraphie (MPS), durchgeführt als Single-Photonen-Emissions-Computer-Tomographie (SPECT), ist ein etabliertes nichtinvasives Verfahren in der Diagnostik der koronaren Herzkrankheit mit hoher prognostischer Aussagekraft. Limitationen entstehen durch Bildartefakte, welche die Sensitivität und insbesondere die Spezifität der MPS herabsetzen. Die inhomogene Schwächung der Photonen im Thorax wird hierbei als wesentlicher Faktor angesehen. Unterschiedliche Ansätze zur Durchführung einer individuellen Schwächungskorrektur werden derzeit von den Kameraherstellern angeboten. Ziel ist, die Emissionsdaten mittels einer Transmissionsaufnahme, die die Verteilung der verschiedenen schwächenden Gewebe im Körper wiedergibt, zu überlagern bzw. zu korrigieren, um so den Einfluss der inhomogenen Photonenabsorption zu eliminieren. Größere Studien haben gezeigt, dass auf diese Weise die Spezifität der MPS verbessert wird, bei nahezu unveränderter Sensitivität. Dreh- und Angelpunkt einer erfolgreichen Schwächungskorrektur bei der MPS sind entsprechende Qualitätskontrollen und Erfahrung von ärztlicher und physikalisch-technischer Seite.

Abstract

Myocardial perfusion imaging has been proved as an accurate, noninvasive method for diagnosis of coronary artery disease with a high prognostic value. However image artifacts, which decrease sensitivity and in particular specificity, degrade the clincal impact of this method. Soft tissue attenuation is regarded as one of the most important factors of impaired image quality. Different approaches to correct for tissue attenuation have been implemented by the camera manufacturers. The principle is to derive an attenuation map from the transmission data and to correct the emission data for nonuniform photon attenuation with this map. There have been several reports published demonstrating an improved specificity with no substantial change in sensitivity by this method. To accurately perform attenuation correction quality control measurements and adequate training of technologists and physicians are mandatory.

Literatur

  • 1 Araujo L I, Jimenez-Hoyuela J M, McClellan J R, Lin E, Viggiano J, Alavi A. Improved uniformity in tomographic myocardial perfusion imaging with attenuation correction and enhanced acquisition and processing.  J Nucl Med. 2000;  41 1139-1144
  • 2 Bailey D L, Meikle S R. Does attenuation correction work?.  J Nucl Med. 2000;  41 960-961
  • 3 Corbett J R, Ficaro E P. “Attenuation compensation of cardiac SPECT: a critical look at a confusing world” by Wackers FJTh.  J Nucl Cardiol. 2003;  10 214-216
  • 4 DePuey E G, Garcia E V. Optimal specificity of thallium-201 SPECT through recognition of imaging artifacts.  J Nucl Med. 1989;  30 441-449
  • 5 DePuey E G, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact.  J Nucl Med. 1995;  36 952-955
  • 6 DePuey E G. Imaging guidelines for transmission-emission tomographic systems to be used for attenuation correction.  J Nucl Cardiol. 2001;  8 G51-G58
  • 7 Eisner R L, Tamas M J, Cloninger K, Shonkoff D, Oates J A, Gober A M, Dunn D W, Malko J A, Churchwell A L, Patterson R E. Normal SPECT thallium-201 bull's-eye display: gender differences.  J Nucl Med. 1988;  29 1901-1909
  • 8 Ficaro E P. Should SPET attenuation correction be more widely employed in routine clinical practice? For.  Eur J Nucl Med Mol Imaging. 2002;  29 409-412
  • 9 Ficaro E P, Fessler J A, Shreve P D, Kritzman J N, Rose P A, Corbett J R. Simultaneous transmission/emission myocardial perfusion tomography. Diagnostic accuracy of attenuation-corrected 99mTc-sestamibi single-photon emission computed tomography.  Circulation. 1996;  93 463-473
  • 10 Fricke E, Fricke H, Esdorn E, Lindner O, Weise R, Burchert W. Evaluierung einer CT-basierten Schwächungskorrektur in der Myokardszintigraphie.  Nuklearmedizin. 2003;  42 A88-A89
  • 11 Gallowitsch H J, Sykora J, Mikosch P, Kresnik E, Unterweger O, Molnar M, Grimm G, Lind P. Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities.  Eur J Nucl Med. 1998;  25 220-228
  • 12 Gerson M, Singh B, Lukes J, Baumann B. Comparison of attenuation and compton scatter corrected to uncorrected thallium-201 tomograms for diagnosis of coronary artery disease (CAD) [abstract].  J Nucl Med. 1999;  40 89
  • 13 Gibson P B, Demus D, Noto R, Hudson W, Johnson L L. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain.  J Am Coll Cardiol. 2002;  39 999-1004
  • 14 Gregoriou G K, Tsui B M, Gullberg G T. Effect of truncated projections on defect detection in attenuation-compensated fanbeam cardiac SPECT.  J Nucl Med. 1998;  39 166-175
  • 15 Heller G, Links J, Bateman T, Ziffer J, Ficaro E, Cohen M, Hendel R.. The Amercian Society of Nuclear Cardiology and The Society of Nuclear Medicine .Joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy. www.asnc.org/resources/jointposstatement_attcor.pdf. 2003
  • 16 Hendel R C, Berman D S, Cullom S J, Follansbee W, Heller G V, Kiat H, Groch M W, Mahmarian J J. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging.  Circulation. 1999;  99 2742-2749
  • 17 Hendel R C, Corbett J R, Cullom S J, DePuey E G, Garcia E V, Bateman T M. The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position statement from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine.  J Nucl Cardiol. 2002;  9 135-143
  • 18 Kammeier A, Lindner O, Weise R, Burchert W. Nuklearmedizin als Paradigma molekularer Bildgebung. Abstractband der 40. Jahrestagung der DGN in Freiburg, 10.-13.04.2002. Blackwell, Berlin 2002; 75
  • 19 Kluge R, Sattler B, Seese A, Knapp W H. Attenuation correction by simultaneous emission-transmission myocardial single-photon emission tomography using a technetium-99m-labelled radiotracer: impact on diagnostic accuracy.  Eur J Nucl Med. 1997;  24 1107-1114
  • 20 Lenzo N, Ficaro N, Kritzman J, Corbett J. Clinical comparison of Profile attenuation correction and the Michigan modified STEPP methods [abstract].  J Nucl Cardiol. 2001;  8 19
  • 21 Links J M, Becker L C, Rigo P, Taillefer R, Hanelin L, Anstett F, Burckhardt D, Mixon L. Combined corrections for attenuation, depth-dependent blur, and motion in cardiac SPECT: a multicenter trial.  J Nucl Cardiol. 2000;  7 414-425
  • 22 Links J M, DePuey E G, Taillefer R, Becker L C. Attenuation correction and gating synergistically improve the diagnostic accuracy of myocardial perfusion SPECT.  J Nucl Cardiol. 2002;  9 183-187
  • 23 Matsunari I, Boning G, Ziegler S I, Nekolla S G, Stollfuss J C, Kosa I, Ficaro E P, Schwaiger M. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose.  J Am Coll Cardiol. 1998;  32 927-935
  • 24 Narayanan M V, King M A, Pretorius P H, Dahlberg S T, Spencer F, Simon E, Ewald E, Healy E, MacNaught K, Leppo J A. Human-observer receiver-operating-characteristic evaluation of attenuation, scatter, and resolution compensation strategies for 99mTc myocardial perfusion imaging.  J Nucl Med. 2003;  44 1725-1734
  • 25 O'Connor M K, Kemp B, Anstett F, Christian P, Ficaro E P, Frey E, Jacobs M, Kritzman J N, Pooley R A, Wilk M. A multicenter evaluation of commercial attenuation compensation techniques in cardiac SPECT using phantom models.  J Nucl Cardiol. 2002;  9 361-376
  • 26 Prvulovich E M, Jarritt P H, Lonn A H, Vorontsova E, Bomanji J B, Ell P J. Influence of arm positioning on tomographic thallium-201 myocardial perfusion imaging and the effect of attenuation correction.  Eur J Nucl Med. 2000;  27 1349-1355
  • 27 Sorenson J, Phelps M. Physics in Nuclear Medicine. 2nd ed. W.B. Saunders Company, Philadelphia 1987
  • 28 Stowers S A, Umfrid R. Supine-prone SPECT myocardial perfusion imaging: the poor man's attenuation compensation.  J Nucl Cardiol. 2003;  10 338
  • 29 Vidal R, Buvat I, Darcourt J, Migneco O, Desvignes P, Baudouy M, Bussiere F. Impact of attenuation correction by simultaneous emission/transmission tomography on visual assessment of 201Tl myocardial perfusion images.  J Nucl Med. 1999;  40 1301-1309
  • 30 Wackers F J. Attenuation correction, or the emperor's new clothes?.  J Nucl Med. 1999;  40 1310-1312
  • 31 Wackers F J. Should SPET attenuation correction be more widely employed in routine clinical practice? Against.  Eur J Nucl Med Mol Imaging. 2002;  29 412-415
  • 32 Watson D. Acquisition, processing, and quantification of nuclear cardiac images. In: Iskandrian AS, Verani MS (eds). Nuclear cardiac imaging. Oxford University Press, New York 2003; 74-90

Dr. Oliver Lindner

Institut für molekulare Biophysik, Radiopharmazie und Nuklearmedizin · Herz- und Diabeteszentrum NRW · Universitätsklinik der Ruhr-Universität Bochum

Georgstr. 11

32545 Bad Oeynhausen

Phone: +49/57 31/97 13 09

Fax: +49/57 31/97 21 90

Email: olindner@hdz-nrw.de

    >